Sunday, 17 December 2017
Latest news
Main » AbbVie (ABBV) PT Set at $84.00 by BMO Capital Markets

AbbVie (ABBV) PT Set at $84.00 by BMO Capital Markets

07 December 2017

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. While, the analyst predicted that the company could provide an EPS of $1.39/share. (NYSE:ABBV). Shelton Mngmt invested 0.41% in AbbVie Inc. Df Dent And has invested 0.01% in AbbVie Inc. Greatmark Investment Partners Inc. grew its stake in shares of AbbVie by 1.7% during the 1st quarter. Segall Bryant & Hamill Llc sold 15,434 shares as Abbvie Inc (ABBV)'s stock rose 6.17%. Sandy Spring Bancorporation invested in 110,914 shares or 0.79% of the stock. San Francisco Sentry Gru (Ca) accumulated 0.07% or 2,659 shares. Shamrock Asset Management Limited Liability Corp invested in 0.1% or 2,301 shares. Hanson & Doremus Inv, Vermont-based fund reported 5,609 shares. Amica Mutual holds 84,346 shares or 0.56% of its portfolio. Focused Wealth Management has invested 0.04% in AbbVie Inc. Alethea Capital Limited Com holds 0.66% of its portfolio in AbbVie Inc.

Shares of AbbVie (ABBV) traded up $0.19 during midday trading on Wednesday, reaching $95.41. On Monday, June 6 the stock rating was downgraded by Cowen & Co to "Market Perform".

Since June 14, 2017, it had 0 buys, and 2 insider sales for $8.79 million activity. 45,800 shares were sold by ALBAN CARLOS, worth $3.21 million on Wednesday, June 14.

Summit Creek Advisors Llc decreased its stake in Icon Plc (ICLR) by 6.83% based on its latest 2017Q2 regulatory filing with the SEC. The institutional investor held 343,700 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $24.92M, down from 606,800 at the end of the previous reported quarter. The stock traded with the average Volume of 6.86 Million at the end of last session. The stock decreased 0.94% or $0.9 during the last trading session, reaching $94.51.

AbbVie Inc. (ABBV) has an annual dividend of $2.84, while its annual dividend yield is 2.98%. It has underperformed by 6.07% the S&P500.

City mayor allegedly used the disabled parking badges of dead people
Police said they received a tip-off last month regarding the mayor using handicap parking spot at Davenport City Hall. A search warrant was issued, deputies say, and found the two placards belonging to two different people.

Walleye Trading Llc, which manages about $16.31B US Long portfolio, upped its stake in Advanced Micro Devices Inc (Put) (NASDAQ:AMD) by 1.79 million shares to 2.16 million shares, valued at $26.94 million in 2017Q2, according to the filing. It also increased its holding in Gentherm Inc (NASDAQ:THRM) by 32,026 shares in the quarter, for a total of 267,933 shares, and has risen its stake in Neogenomics (NASDAQ:NEO). During the key period of last 5 years, AbbVie Inc.

The (Simple Month Average) SMA20 is at 0.48 percent, its SMA50 Value is 3.04% and SMA200 value is reported as 26.46 Percent. During the same quarter previous year, the firm posted $1.21 earnings per share. The company has a market cap of $106.17 billion, a PE ratio of 17.29 and a beta of 1.57. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.02.

The collective rating of 2.3 for AbbVie Inc. (NYSE:ABBV) news were published by: Nasdaq.com which released: "AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan" on December 06, 2017, also Washingtonpost.com with their article: "AbbVie Promises Too Much, Risks Delivering Too Little: Gadfly" published on November 06, 2017, Seekingalpha.com published: "AbbVie Raises Dividend 11%..." Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. "What Now?" on December 04, 2017, also Seekingalpha.com with their article: "AbbVie's risankizumab successful in fourth late-stage psoriasis study" published on December 04, 2017, Fool.com published: "The case for Johnson & Johnson" on November 21, 2017. What Now?" with publication date: "December 04, 2017. For AbbVie Inc. (NYSE:ABBV), Stochastic %D value stayed at 44.75% for the last 9 days. Therefore 100% are positive. AbbVie has a 52 week low of $55.06 and a 52 week high of $68.12. The stock was sold at an average price of $94.01, for a total value of $20,512,323.93. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. (NYSE:ABBV) on Monday, December 7 to "Buy" rating. Cincinnati Specialty Underwriters Co has invested 1.8% in AbbVie Inc. (NYSE:ABBV) has "Market Perform" rating given on Friday, June 10 by BMO Capital Markets. SunTrust initiated the stock with "Buy" rating in Wednesday, July 22 report.

In related news, VP Robert A. Michael sold 6,699 shares of AbbVie stock in a transaction dated Thursday, September 28th. As per Friday, April 28, the company rating was maintained by BMO Capital Markets. They set an "outperform" rating and a $95.00 target price on the stock. (NYSE:ABBV) for 6,720 shares. RBC Capital Markets maintained The Toronto-Dominion Bank (TSE:TD) rating on Tuesday, October 25. The rating was initiated by William Blair on Friday, February 5 with "Outperform". On Thursday, November 10 the stock rating was downgraded by Morgan Stanley to "Equal-Weight".

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.